| 1. |
Bakthavatchalam M, Lai FHP, Rong SS, et al. Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review[J]. Surv Ophthalmol, 2018, 63(3): 329-339. DOI: 10.1016/j.survophthal.2017.09.009.
|
| 2. |
Chen C, Liu X, Peng X. Management of cystoid macular edema in retinitis pigmentosa: a systematic review and meta-analysis[J/OL]. Front Med (Lausanne), 2022, 9: 895208[2022-05-16]. https://pubmed.ncbi.nlm.nih.gov/35652079/. DOI: 10.3389/fmed.2022.895208.
|
| 3. |
Strong S, Liew G, Michaelides M. Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention[J]. Br J Ophthalmol, 2017, 101(1): 31-37. DOI: 10.1136/bjophthalmol-2016-309376.
|
| 4. |
Park UC, Park JH, Yoon CK, et al. Microstructral changes in cystoid macular edema in retinitis pigmentosa after intravitreal dexamethasone implant injection[J]. Retina, 2021, 41(4): 852-860. DOI: 10.1097/IAE.0000000000002944.
|
| 5. |
Karasu B. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors[J]. Int Ophthalmol, 2020, 40(3): 677-687. DOI: 10.1007/s10792-019-01228-z.
|
| 6. |
Mansour AM, Sheheitli H, Kucukerdonmez C, et al. Intravitreal dexamethasone implant in retinitis pigmentosa-related cystoid mcular edema[J]. Retina, 2018, 38(2): 416-423. DOI: 10.1097/IAE.0000000000001542.
|
| 7. |
Veritti D, Sarao V, De Nadai K, et al. Dexamethasone implant produces better outcomes than oral acetazolamide in patients with cystoid macular edema secondary to retinitis pigmentosa[J]. J Ocul Pharmacol Ther, 2020, 36(3): 190-197. DOI: 10.1089/jop.2018.0153.
|
| 8. |
Park UC, Park JH, Ma DJ, et al. A randomized paired-eye trial of intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa[J]. Retina, 2020, 40(7): 1359-1366. DOI: 10.1097/IAE.0000000000002589.
|
| 9. |
Strong SA, Peto T, Bunce C, et al. Prospective exploratory study to assess the safety and efficacy of Aflibercept in cystoid macular oedema associated with retinitis pigmentosa[J]. Br J Ophthalmol, 2020, 104(9): 1203-1208. DOI: 10.1136/bjophthalmol-2019-315152.
|
| 10. |
Arslan U. Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser[J]. Lasers Med Sci, 2021, 36(2): 317-323. DOI: 10.1007/s10103-020-03031-0.
|
| 11. |
García-Arumí J, Martinez V, Sararols L, et al. Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa[J]. Ophthalmology, 2003, 110(6): 1164-1169. DOI: 10.1016/S0161-6420(03)00259-8.
|
| 12. |
Kim YJ, Joe SG, Lee DH, et al. Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa[J]. Invest Ophthalmol Vis Sci, 2013, 54(2): 1303-1309. DOI: 10.1167/iovs.12-10149.
|
| 13. |
Koyanagi Y, Murakami Y, Funatsu J, et al. Optical coherence tomography angiography of the macular microvasculature changes in retinitis pigmentosa[J/OL]. Acta Ophthalmol, 2018, 96(1): e59-e67[2017-05-31]. https://pubmed.ncbi.nlm.nih.gov/28561452/. DOI: 10.1111/aos.13475.
|
| 14. |
Walia S, Fishman GA, Hajali M. Prevalence of cystic macular lesions in patients with Usher II syndrome[J]. Eye (Lond), 2009, 23(5): 1206-1209. DOI: 10.1038/eye.2008.105.
|
